Bessemer Group’s Avidity Biosciences RNAM Stock Holding History

Bessemer Group’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-254	Closed	-$18K	–	2658
2025 Q4	$18K	Hold	254	–	–	﹤0.01%	1926
2025 Q3	$11K	Buy	254 +97	+62%	+$3.92K	﹤0.01%	1920
2025 Q2	$4K	Sell	157 -500	-76%	-$14.9K	﹤0.01%	2087
2025 Q1	$20K	Sell	657 -3,953	-86%	-$123K	﹤0.01%	1543
2024 Q4	$134K	Hold	4,610	–	–	﹤0.01%	1151
2024 Q3	$212K	Buy	+4,610	New	+$200K	﹤0.01%	1101

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

Bessemer Group's RNAM Position: Q1 2026 in Review

Bessemer Group sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 254 shares — an estimated $18K sold.

Bessemer Group first reported a position in RNAM in Q3 2024 and held it in 6 quarters. The position peaked at $212K in Q3 2024. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Bessemer Group reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Bessemer Group sold 254 Avidity Biosciences shares in Q1 2026, an estimated $18K.
Bessemer Group first reported a position in Avidity Biosciences in Q3 2024 and held it in 6 quarters.
Bessemer Group's Avidity Biosciences position peaked at $212K in Q3 2024.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Bessemer Group's 13F filing for Q1 2026, filed 6 May 2026.